Barclays PLC Integra Lifesciences Holdings Corp Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Barclays PLC holds 168,014 shares of IART stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,014
Previous 168,014
-0.0%
Holding current value
$2.64 Million
Previous $2.06 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding IART
# of Institutions
235Shares Held
78.5MCall Options Held
24.6KPut Options Held
0-
Black Rock Inc. New York, NY11.3MShares$177 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.58MShares$119 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY7.35MShares$115 Million2.08% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$66.1 Million0.26% of portfolio
-
Morgan Stanley New York, NY3.93MShares$61.7 Million0.0% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.31B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...